Ledger.Open graph →
SEC Form D · Amendment · filed April 11, 2019

Abfero Pharmaceuticals, Inc

Offering
$1.0M
Sold
$600K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Thomas X. Neenan · Lexington, MAExec · DirectorSteven X. Burke · Lexington, MAExec · DirectorMichael X. Penington · Lexington, MADirectorJay Bauer · Bellevue, WAExec · DirectorJosh Wand · Bellevue, WADirectorBettina Paek · Mercer Island, WAExec · DirectorCharles L. Gibbon · ALEXANDRIA, Channel IslandsDirectorArlene L. Tansey · ALEXANDRIA, Channel IslandsExec · DirectorMark D'Agostino · GLEN ROCK, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗